NPPHY - BlackRock International Fund Q4 2024 Commentary
2025-03-24 14:50:00 ET
Summary
- BlackRock International Fund posted returns of -4.79% (Institutional shares) and -4.81% (Investor A shares, without sales charge) for the fourth quarter of 2024.
- The top contributors were Sony, Marvell, and Recruit. Novo Nordisk performed weakly due to disappointing Phase 3 results for key anti-obesity drug candidate Cagrisema.
- International markets were weak during the quarter. The U.S. dollar strengthened by 5.6% due to higher Treasury yields following the U.S. election.
Average annual total returns (%) as of 12/31/24
4Q24 (not annualized) |
YTD (not annualized) |
1 Year |
3 Year |
5 Years |
10 Years |
Institutional |
-4.79 |
0.46 |
0.46 |
-3.06 |
3.94 |
4.92 |
Investor A (Without Sales Charge) |
-4.81 |
0.22 |
0.22 |
-3.31 |
3.68 |
4.61 |
Investor A (With Sales Charge) |
-9.80 |
-5.04 |
-5.04 |
-5.03 |
2.57 |
4.05 |
MSCI All Country World ex-U.S. 2 |
-8.01 |
7.50 |
7.50 |
— |
— |
— |